VGXI Opens New Headquarters and Expanded Manufacturing Facility

SourceGenetic Engineering and Biotechnology News
Date Published10/14/2022
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name VGXI
Parent companyGeneOne
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Year reshoring announced:2022
Domestically, the work will be done:In-house
Country(ies) from which reshored:Korea, Republic of
City reshored to:Conroe
State(s) reshored to:TX
If relevant, work nearshored to:-
Product(s) reshoredbiopharmaceuticals
What domestic positive factors made reshoring more attractive?Proximity to customers/market
Find Reshoring Articles